John Kenneth Jenkins, Director at Corbus Pharmaceuticals Holdings, Inc. (CRBP), sold 4,800 shares at $7.91 ($38K) on 2026-06-10, disclosed to the SEC on 2026-06-11.
Scheduled sale ($38k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |